Literature DB >> 16754663

Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains.

Hwee Ching Ang1, Andreas C Joerger1, Sebastian Mayer1, Alan R Fersht2.   

Abstract

Common cancer mutations of p53 tend either to lower the stability or distort the core domain of the protein or weaken its DNA binding affinity. We have previously analyzed in vitro the effects of mutations on the core domain of p53. Here, we extend those measurements to full-length p53, using either the wild-type protein or a biologically active superstable construct that is more amenable to accurate biophysical measurements to assess the possibilities of rescuing different types of mutations by anticancer drugs. The tetrameric full-length proteins had similar apparent melting temperatures to those of the individual domains, and the structural mutations lowered the melting temperature by similar amounts. The thermodynamic stability of tetrameric p53 is thus dictated by its core domain. We determined that the common contact mutation R273H weakened binding to the gadd45 recognition sequence by approximately 700-1000 times. Many mutants that have lowered melting temperatures should be good drug targets, although the common R273H mutant binds response elements too weakly for simple rescue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16754663     DOI: 10.1074/jbc.M604209200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  The novel p53 isoform "delta p53" is a misfolded protein and does not bind the p21 promoter site.

Authors:  Maria M García-Alai; Henning Tidow; Eviatar Natan; Fiona M Townsley; Dmitry B Veprintsev; Alan R Fersht
Journal:  Protein Sci       Date:  2008-07-11       Impact factor: 6.725

2.  Effects of stability on the biological function of p53.

Authors:  Kian Hoe Khoo; Sebastian Mayer; Alan R Fersht
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

3.  Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain.

Authors:  Mark Wells; Henning Tidow; Trevor J Rutherford; Phineus Markwick; Malene Ringkjobing Jensen; Efstratios Mylonas; Dmitri I Svergun; Martin Blackledge; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

4.  Meet me halfway: when genomics meets structural bioinformatics.

Authors:  Sungsam Gong; Catherine L Worth; Tammy M K Cheng; Tom L Blundell
Journal:  J Cardiovasc Transl Res       Date:  2011-02-25       Impact factor: 4.132

5.  Nonsense mutation-dependent reinitiation of translation in mammalian cells.

Authors:  Sarit Cohen; Lior Kramarski; Shahar Levi; Noa Deshe; Oshrit Ben David; Eyal Arbely
Journal:  Nucleic Acids Res       Date:  2019-07-09       Impact factor: 16.971

6.  Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain.

Authors:  Sara Calhoun; Valerie Daggett
Journal:  Biochemistry       Date:  2011-05-17       Impact factor: 3.162

7.  Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function.

Authors:  L Palanikumar; Laura Karpauskaite; Mohamed Al-Sayegh; Ibrahim Chehade; Maheen Alam; Sarah Hassan; Debabrata Maity; Liaqat Ali; Mona Kalmouni; Yamanappa Hunashal; Jemil Ahmed; Tatiana Houhou; Shake Karapetyan; Zackary Falls; Ram Samudrala; Renu Pasricha; Gennaro Esposito; Ahmed J Afzal; Andrew D Hamilton; Sunil Kumar; Mazin Magzoub
Journal:  Nat Commun       Date:  2021-06-25       Impact factor: 14.919

8.  Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers.

Authors:  Jan van Dieck; Maria R Fernandez-Fernandez; Dmitry B Veprintsev; Alan R Fersht
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

9.  Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family.

Authors:  Sebastian Kehrloesser; Christian Osterburg; Marcel Tuppi; Birgit Schäfer; Karen Heather Vousden; Volker Dötsch
Journal:  Cell Death Differ       Date:  2016-07-22       Impact factor: 15.828

10.  Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences.

Authors:  Marie Brázdová; Timo Quante; Lars Tögel; Korden Walter; Christine Loscher; Vlastimil Tichý; Lenka Cincárová; Wolfgang Deppert; Genrich V Tolstonog
Journal:  Nucleic Acids Res       Date:  2009-01-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.